Scarica l'app Stockscreener
10.05
0.16%
0.0156
Precedente Chiudi:
$10.03
Aprire:
$10.04
Volume 24 ore:
800
Relative Volume:
0.01
Capitalizzazione di mercato:
$336.18M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.11%
1M Prestazione:
+0.26%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.03
$10.05
Intervallo di 1 settimana:
$10.03
$10.05
Portata 52W:
$9.96
$10.27
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Nome
Drugs Made In America Acquisition Corp
Settore
Industria
Telefono
954-870-3104
Indirizzo
2 PELICAN DR., FORT LAUDERDALE
Confronta DMAA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.05 | 336.18M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.63 | 1.80B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.20 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.67 | 460.58M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.27 | 451.61M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.09 | 450.63M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Borsa (DMAA) Ultime notizie
WEBTOON Entertainment Inc. (NASDAQ:WBTN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Pfizer Inc. - Britannica
AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica
Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette
'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo
Drugs Made In America Acquisition Corp. (DMAA) reports earnings - qz.com
Bright Green Unveils Massive $2B Cannabis Strategy with Zero Shareholder Dilution - StockTitan
Bright Green Corporation Announces the next steps for the completion of its restructuring plan - The Manila Times
DRUGS MADE IN AMERICA ACQUISITION CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
India-based Syngene acquires its first US biologics site - Manufacturing Dive
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines - Business Wire
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Eli Lilly and Company
A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - CNN
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
NewGen Issues Clarification on Press Release Titled 'NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces Trading Options for Public Offering Units Starting February 25, 2025 - Nasdaq
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
U.S. investors, Big Pharma race to find new medicines in China - CNBC
Drugs Made In America Acquisition Corp.’s $200 Million Initial Public Offering - Global Legal Chronicle
Trump wants to put tariffs on prescription drugs. Experts warn it could backfire. - Yahoo Finance
Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - Fierce Pharma
United Parcel Service (UPS) | History, Services, & Facts - Britannica
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha
IPO NewsUS IPO Weekly Recap: Active January closes out with several sizable IPOs - renaissancecapital.com
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering - The Manila Times
Drugs Made In America Acquisition Prices $200 Million IPO - MarketScreener
Drugs Made in America Acquisition Corp. (DMAAU) Prices $200M IPO - SPAC Insider
Bright Green Corporation Has Signed Agreement with Majority - GlobeNewswire
How UnitedHealth and Rivals Made $7.3 Billion Marking Up Drugs: FTC - Newsweek
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor - The New York Times
How Trump’s Greenland demands could impact Ozempic costs - The Hill
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc. - Johnson & Johnson
The top 10 biopharma M&A deals of 2024 - Fierce Pharma
What Trump’s Denmark Tariff Threat Means for Ozempic Drugmaker Novo Nordisk - Barron's
Analysts Set Elevation Oncology, Inc. (NASDAQ:ELEV) Price Target at $7.20 - Defense World
2024 drug approvals: Small companies loom large with several key FDA nods - Fierce Pharma
Layoffs Continued Across Biopharma in 2024 - BioSpace
Bright Green enters into restructuring security agreement with Lynn Stockwell - Yahoo Finance
Bright Green (BGXX) Announces Major Restructuring: Founder Returns as CEO, Plans API Manufacturing Focus - Stock Titan
Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval - Reuters
Dallas Entrepreneur Seeks to Build Nationwide Compounding Pharmacy Network - Dallas Innovates
7 Companies Owned by Pfizer - Investopedia
Top 10 Asthma Drug Companies | Provides Best Medicines - Market.us Media
FTC’s watchdog role in pharma mergers: Road bumps and the way forward - Norton Rose Fulbright
Drugs Made In America Acquisition Corp Azioni (DMAA) Dati Finanziari
Non sono disponibili dati finanziari per Drugs Made In America Acquisition Corp (DMAA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):